HIBADH Human Pre-designed siRNA Set A contains three designed siRNAs for HIBADH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIBCH Human Pre-designed siRNA Set A contains three designed siRNAs for HIBCH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIC1 Human Pre-designed siRNA Set A contains three designed siRNAs for HIC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIC2 Human Pre-designed siRNA Set A contains three designed siRNAs for HIC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HID1 Human Pre-designed siRNA Set A contains three designed siRNAs for HID1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hide powder Azure is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes are […]

HIF-1α-IN-7 (Compound D13) is a potent HIF-1α inhibitor. HIF-1α-IN-7 has neuroprotective activity. HIF-1α-IN-7 can be used in Alzheimer’s disease research[1].

HIF-2α agonist 3 (Compound 14d) is an orally active HIF-2α agonist with a EC50 value of 1.78 μM. HIF-2α agonist 3 can be used in the study of renal anemia[1].

HIF1A Human Pre-designed siRNA Set A contains three designed siRNAs for HIF1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIF1AN Human Pre-designed siRNA Set A contains three designed siRNAs for HIF1AN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIF3A Human Pre-designed siRNA Set A contains three designed siRNAs for HIF3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIGD1A Human Pre-designed siRNA Set A contains three designed siRNAs for HIGD1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIGD1B Human Pre-designed siRNA Set A contains three designed siRNAs for HIGD1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIKESHI Human Pre-designed siRNA Set A contains three designed siRNAs for HIKESHI gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HILPDA Human Pre-designed siRNA Set A contains three designed siRNAs for HILPDA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Himic anhydride is an anhydride modified cantharidin analogue that inhibits protein phosphatase 2A. Himic anhydride can be used in asthma research[1][2].

Himic anhydride is an anhydride modified cantharidin analogue that inhibits protein phosphatase 2A. Himic anhydride can be used in asthma research[1][2].

HINT1 Human Pre-designed siRNA Set A contains three designed siRNAs for HINT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HINT2 Human Pre-designed siRNA Set A contains three designed siRNAs for HINT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HINT3 Human Pre-designed siRNA Set A contains three designed siRNAs for HINT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for HIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIP1R Human Pre-designed siRNA Set A contains three designed siRNAs for HIP1R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIPK1 Human Pre-designed siRNA Set A contains three designed siRNAs for HIPK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIPK2 Human Pre-designed siRNA Set A contains three designed siRNAs for HIPK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIPK3 Human Pre-designed siRNA Set A contains three designed siRNAs for HIPK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIPK4 Human Pre-designed siRNA Set A contains three designed siRNAs for HIPK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIRA Human Pre-designed siRNA Set A contains three designed siRNAs for HIRA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HIRIP3 Human Pre-designed siRNA Set A contains three designed siRNAs for HIRIP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Histamine (Standard) is the analytical standard of Histamine. This product is intended for research and analytical applications.

Histamine H3 antagonist-1 (Compound 10o) is a histamine H3 antagonist and a serotonin reuptake inhibitor, which can be used in depression research[1].

Histamine/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Histamine (HY-B1204) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases[1].

Histamine/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Histamine (HY-B1204) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases[1].

HIV gp120 254-274 is a conserved fragment in envelope glycoprotein gp120 of human immunodeficiency virus (HIV), and exhibits immunosilent activity[1].

HIV gp120 308-331 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody[1].

HIV gp120 421-438 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody[1].

HIV-1 inhibitor-64 (Compound 7c) is a wild-type HIV-1 inhibitor that effectively suppresses the activity of HIV-1 mutants E138K/Q148K and G140S/Q148R with EC50 values of 62.5 nM and 11.3 nM, respectively. HIV-1 inhibitor-64 exhibits antiviral activity and can be used in the research of AIDS[1].

HIV-1 inhibitor-65 (compound 3c) is an inhibitor of HIV-1 (EC50: 2.9 nM) and an activator of protein kinase C (PKC). HIV-1 inhibitor-65 inhibits syncytium formation (EC50: 7.0 nM) and inhibits HIV-1 entry and HIV-1 reverse transcriptase[1].

HIV-1 inhibitor-66 is an orally active non-nucleoside reverse transcription inhibitor (NNRTI). HIV-1 inhibitor-66 shows inhibitory activity against wild-type HIV-1 reverse transcriptase with an IC50 of 40 nM[1].

HIV-1 protease-IN-13 (compound 18d) is a potent HIV-1 protease inhibitor with an IC50 value of 0.54 nM. HIV-1 protease-IN-13 also shows potent activity against HIV-1DRVRS (DRV-resistant mutation) and HIV-1NL4_3 variant (wild type)[1].